Novel Medical Use
OwnerDavid Lipsoninventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to a compound which is (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol or a pharmaceutically acceptable salt thereof for use in the treatment or prevention of inflammatory and non-inflammatory diseases abd conditions associated with alveolar filling.
Claims11
A compound which is (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol:
- or a pharmaceutically acceptable salt thereof for use in the treatment or prevention of inflammatory and non-inflammatory diseases and conditions associated with alveolar filling.
6-11. (canceled)
A method for the treatment or prevention of inflammatory and non-inflammatory diseases and conditions associated with alveolar filling, to a human in need thereof, which method comprises administering an effective amount of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.